21 structural-engineering "https:" "https:" "https:" "https:" "The University of Manchester" positions
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
Application deadline: 31/03/2026 Research theme: Biocatalysis and Protein Engineering Centre for Sustainable Synthesis – BioProcess How to apply: https://www.mib.manchester.ac.uk/research/centres
-
successful candidate will join the PhD programme of the Department of Mathematics at the University of Manchester. This 42-month PhD position (funded by the University of Manchester) is a full scholarship
-
research associate in Modelling X-ray Spectroscopies for the Nuclear Fuel Cycle working with the Oakley group, Department of Chemistry, School of Natural Sciences, The University of Manchester. Applications
-
, physical and chemical processes are likely to have led to significant changes in the physical, structural and chemical properties of the zeolite minerals over this period. For example, the high doses of both
-
of Manchester, and is funded by the University of Manchester and the UK Engineering and Physical Sciences Research Council (EPSRC). The role of the post-doctoral research associate is to engage in developing new
-
Contract Duration: Contract duration will depend on start date until 30-Jun-27 in the first instance The University of Manchester (www.manchester.ac.uk) is one of the largest single-site
-
The University of Manchester (www.manchester.ac.uk) is one of the largest single-site universities in the UK, with one of the biggest student communities. In total, 25 Nobel Prize winners have
-
. The lab is located in the Manchester Institute of Biotechnology (MIB), a unique cross-disciplinary research institute at the University of Manchester, which brings together more than 450 researchers with
-
and materials engineering. They will do this by integrating modern data-centric approaches, such as physics-informed machine learning, structure-aware modelling, and digital-twin methodologies, with
-
understanding of the chemical, structural and molecular biology of disease, and the expertise in medicinal chemistry is now required to develop suitable targeting approaches and candidate entities. The successful